PHI 09/26 Spinal Cord Stimulator post-listing review impact assessment

We are commencing an impact assessment on the proposed outcomes from the Prescribed List spinal cord stimulator (SCS) post-listing review

Date published:
PHI circular type:
PHI announcement

We are completing an impact assessment on the proposed outcomes of the spinal cord stimulator (SCS) post-listing review. The impact assessment will examine the potential impacts of the proposed changes to SCS devices on the Prescribed List.

We have published a draft department report which outlines the review process, findings and proposed outcomes. Stakeholders can provide feedback on the draft report and proposed changes via our consultation hub. The consultation will close at 4pm on 23 March 2026.

Key stakeholders have been contacted directly and invited to provide feedback on the report and proposed changes.

For further information, please contact us at prescribedlist.reviews@health.gov.au